PJX reports 42% decline in year-end net profit

May 1, 2025

Portland JSX Limited (PJX)

Audited financials for the twelve months ended February 28, 2025:

Portland JSX Limited (PJX) reported a 47% increase in Net gain on financial assets classified as at fair value through a loss totaling US$3.16 million for the twelve months ended February 28, 2025, compared to a loss of US$5.99 million in the corresponding period last year. Net gain on financial assets classified as at fair value through Profit or Loss for the fourth quarter had a 79% increase to close at a loss of US$3.10 million compared to a loss of US$14.48 million for the comparable quarter of 2024.

Interest income from loans and receivables amounted to US$228,501 (2024: US$189,687), an increase of 20% yearly. Consequently, there was no dividend income for the period compared to US$63,889 for the twelve months ended February 28, 2024.

Foreign Exchange Gain increased by 275% to close at US$19,563 (2024: loss of US$11,151), while Net interest expense decreased by 49% from US$5.75 million in 2024 to US$2.91 million in the period under review. As a result, operating expenses for the twelve months ended February 28, 2025, amounted to US$1.02 million, a 5% increase relative to US$968,763 reported in 2024.

Operating loss before finance costs for the twelve months ended February 28, 2025, amounted to US$3.92 million, a 43% increase relative to a loss of US$6.88 million reported in 2024. Operating loss before finance costs for the fourth quarter amounted to US$3.41 million (2024: profit of US$1.80 million). No dividends were paid to holders of redeemable preference shares over the last 12 months, which represents a 100% decrease from last year’s corresponding period (2024: US$51,111).

Interest Expense on bond payable for the twelve months ended February 28, 2025, amounted to US$307,035, a 2% decrease relative to US$313,233 reported in 2024. Interest Expense on bonds payable for the fourth quarter amounted to US$76,610 (2024: US$66,536).

Loss for the twelve months ended February 28, 2025, increased by 42% to reach US$4.23 million (2024: Loss of US$7.24 million). For the fourth quarter, the loss for the period was US$3.49 million (2024: profit of US$1.73 million).

Consequently, Loss Per Share for the twelve months amounted to US 1.37 cents (2024: loss per share US 2.34 cents), while Loss Per Share for the quarter totaled US 1.12 cents (2024: EPS: US 0.56 cents). The twelve-month trailing LPS was J$2.15, and the number of shares used in these calculations was 309,968,261.

Notably, PJX’s stock closed the trading period on April 30, 2025, at 10.70.

Balance Sheet Highlights

The company’s assets totaled US$24.57 million (2024: US$27.97 million). The overall reduction in the company’s asset base is due to a 25% year-over-year decline in financial investments, which ended the year at US$18.51 million (compared to US$24.59 million in 2024), a 66% drop in securities purchased under resale agreements, closing the year at US$176,610 (down from US$523,936 in 2024), and a 63% decrease in loans and receivables, which ended the year at US$29,391 (versus US$80,236 in 2024).

Shareholder’s equity was US$19.79 million (2024: US$24.03 million), representing a book value per share of US 6.39 cents (2024: US 7.75 cents).

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…